DaVita First-Quarter 2025 Financial Results: Just the Numbers
In This Article:
Getty Images
Kidney treatment company DaVita (DVA) on Monday afternoon reported first-quarter 2025 financial results. A summary of its key numbers is below. Read the company’s earnings press release here.
| Table | Q1 2025 | Estimate* | Q1 2024 |
| Revenue | $3.22B | $3.21B | $3.07B |
| Net Income** | $163M | $139M | $205M |
| EPS*** | $2.00 | $1.68 | $2.26 |
* Estimates reflect the pre-earnings means from Visible Alpha.
** Net income reflects the company's reported adjusted number.
*** Earnings per share reflects the company’s reported adjusted and diluted number.
Read the original article on Investopedia
Terms and Privacy Policy